Workflow
CHICMAX(02145)
icon
Search documents
上美股份预计上半年净利润同比增长30.9%—35.8%
Group 1 - The performance growth is primarily attributed to the multi-channel and multi-category layout of the Han Shu brand and the significant revenue increase from Newpage [1] - The company continues to implement a "single focus, multiple brands, globalization" strategy, establishing a multi-brand matrix consisting of "Han Shu + Newpage + Nth Curve Brands" [1] - The main brand Han Shu achieved a GMV of 3.63 billion yuan on Douyin, maintaining the top position in the beauty sales ranking on the platform, with product breakthroughs in various categories such as Hong Man Yao, Bai Man Yao, X Peptide series, and secondary throwaway products [1] Group 2 - The professional skincare brand An Min You has entered the sensitive skin market with the "Qinghao Oil AN+" ingredient, enhancing the professional skincare portfolio [1] - The company's layout in the hair care sector includes brands like Ji Fang and Han Shu Hair Care, precisely targeting the "functional hair care" and "scalp anti-aging" niche markets [1] Group 3 - The company expects its net profit for the first half of 2025 to be between 540 million yuan and 560 million yuan, representing a year-on-year growth of 30.9% to 35.8% [3] - The expected revenue for the company is between 4.09 billion yuan and 4.11 billion yuan, with a year-on-year growth of 16.8% to 17.3% [3]
上美股份上半年度净利同比预增30.9%—35.8%
Bei Jing Shang Bao· 2025-08-05 14:04
北京商报讯(记者 张君花)8月5日,上美股份发布半年度正面盈利预告称,预计截至2025年6月30日止 六个月内,公司收入约为40.9亿元至41.1亿元,较去年同期增长约16.8%至17.3%;净利润约为5.4亿元至 5.6亿元,较去年同期增长约30.9%至35.8%。收入和利润的增长主要归因于科学抗衰护肤品牌的全渠道 多品类布局以及婴童功效护肤品牌的收入大幅增长。 ...
上美股份盈喜:预计2025年上半年净利润约5.4亿至5.6亿元 涨幅30.9%-35.8%
Zhi Tong Cai Jing· 2025-08-05 13:50
Core Viewpoint - Shanghai Shangmei Cosmetics Co., Ltd. (02145) has released a positive profit forecast for the first half of 2025, indicating strong revenue and net profit growth driven by its main brand Han Shu and the second growth curve brand New Page [1][2][4] Group 1: Financial Performance - For the first half of 2025, the company expects revenue to be between RMB 4.09 billion and RMB 4.11 billion, representing a year-on-year growth of 16.8% to 17.3% [1] - The net profit is projected to reach between RMB 540 million and RMB 560 million, showing a significant year-on-year increase of 30.9% to 35.8% [1] Group 2: Brand Strategy - The company is advancing a "single focus, multi-brand, globalization" strategy, creating a multi-brand matrix that includes the main brand Han Shu and the second curve brand New Page, achieving comprehensive layout across multiple categories and price ranges [2][12] - Han Shu has achieved a breakthrough in all-channel growth, with GMV on Douyin exceeding RMB 3.63 billion in the first half of 2025, maintaining its position as the top beauty brand on the platform [4][12] Group 3: Product Innovation - The Han Shu brand has successfully launched popular products, such as the Hong Man Yao series, which sold over 14 million sets, and the Bai Man Yao series, which continues to grow in the whitening market [4][9] - New Page has shown strong growth since its launch in 2022, with a strategic upgrade targeting "effective skincare for all ages" and achieving a sales increase of 106% during the 618 shopping festival [6][12] Group 4: Competitive Advantage - The An Min You brand targets the sensitive skin segment, utilizing innovative ingredients like Qinghao Oil AN+ to provide gentle solutions, enhancing the company's competitive edge in professional skincare [9][12] - The company has established a complete innovation matrix in the hair care sector, focusing on functional hair care and scalp anti-aging products, driven by consumer demand [9][12] Group 5: Future Outlook - The company aims to achieve a strategic goal of RMB 30 billion by 2030, leveraging clear strategic planning and ongoing research investment to transition from following international brands to leading industry development [19]
上美股份(02145.HK)盈喜:预计2025年上半年营收超40.9亿元,净利润飙升超30.9%
Ge Long Hui· 2025-08-05 13:08
Core Viewpoint - Shanghai Shangmei Cosmetics Co., Ltd. (02145.HK) has released a positive profit forecast for the first half of 2025, indicating strong revenue and net profit growth driven by its main brand Han Shu and the second growth curve brand New Page [1][2] Group 1: Financial Performance - For the first half of 2025, the company expects revenue to be between RMB 4.09 billion and RMB 4.11 billion, representing a year-on-year growth of 16.8% to 17.3% [1] - The net profit is projected to reach between RMB 540 million and RMB 560 million, showing a significant year-on-year increase of 30.9% to 35.8% [1] Group 2: Brand Strategy - The company is advancing a "single focus, multi-brand, globalization" strategy, creating a multi-brand matrix that includes the main brand Han Shu and the second curve brand New Page, achieving comprehensive layout across multiple categories and price ranges [2][10] - Han Shu has achieved a breakthrough in all-channel growth, with GMV on Douyin exceeding RMB 3.63 billion in the first half of 2025, maintaining its position as the top-selling beauty brand on the platform [4] Group 3: Product Innovation - The Han Shu brand has successfully launched innovative products, such as the Hong Man Yao series, which sold over 14 million sets, and the Bai Man Yao series targeting the whitening market, reinforcing the brand's market recognition for "functional skincare" [4] - New Page has shown strong growth since its launch in 2022, with a strategic upgrade focusing on "effective skincare" for all age groups, achieving a sales increase of 106% during the 618 shopping festival [6] Group 4: Competitive Advantage - The Anminyou brand targets the sensitive skin segment with its core ingredient "Artemisia Oil AN+", providing a gentle solution for sensitive skin, enhancing the company's professional skincare portfolio [8] - The company has established a complete innovation matrix in the hair care sector, launching differentiated brands like Jifang and Han Shu Hair Care, focusing on functional hair care and scalp anti-aging [8] Group 5: Research and Development - The company emphasizes R&D as a strategic priority, having established a 3.0 innovation R&D system and an "1+N open innovation platform" to integrate global scientific resources [11] - In 2024, Han Shu achieved a significant technological breakthrough with the approval of its self-developed cyclic peptide-9 anti-aging ingredient by the National Medical Products Administration [13] Group 6: Manufacturing and Future Goals - The company has built an international and intelligent production system, with a smart factory that operates fully automated processes from raw material scheduling to finished product delivery [14] - The company aims to reach a strategic target of RMB 30 billion by 2030, leveraging clear strategic planning and continuous R&D investment to transition from following international brands to leading industry development [16]
创科实业中期营收约78亿美元 百胜中国二季度经营利润同比增逾一成
Xin Lang Cai Jing· 2025-08-05 12:18
Performance Summary - Techtronic Industries (00669.HK) reported a revenue of $7.8 billion for the first half of the year, an increase of 7.5% year-on-year, with a net profit of $628 million, up 14.2% [1] - Yum China (09987.HK) achieved revenue of $2.8 billion in Q2 2025, a 4% increase year-on-year, with an operating profit of $304 million, up 14% [1] - Shiseido (02145.HK) expects mid-term revenue of approximately ¥4.09-4.11 billion, a year-on-year increase of about 16.8%-17.3%, and a net profit of approximately ¥540-560 million, up about 30.9%-35.8% [1] - Prosperity Industrial Trust (00778.HK) reported revenue of approximately HK$854 million for the first half, a decrease of about 2% year-on-year, while distributable income to unitholders increased by 2.06% to HK$377 million [1] - Zibuyu (02420.HK) anticipates mid-term revenue of approximately RMB 1.9-2.047 billion, a year-on-year increase of about 30%-40%, with a net profit of approximately RMB 100-110 million, up about 10%-20% [1] - Angelalign Technology (06699.HK) expects mid-term net profit of approximately $13.4-14.8 million, a year-on-year increase of approximately 538.1%-604.8% [1] Company News - Sunac China (01918.HK) reported a cumulative contract sales amount of ¥25.08 billion for the first seven months of 2025, a decrease of 9.43% year-on-year, with July contract sales of approximately ¥1.53 billion, an increase of 8.51% [3] - Xingye Holdings (00132.HK) entered into a financing lease agreement with Heilongjiang Mudanjiang Agricultural Reclamation Xinneng Thermal Power, involving an investment of ¥100 million [3] - China Biopharmaceutical (01177.HK) received NMPA approval for the clinical trial application of TQC3302, an ICS/LAMA/LABA soft mist inhalation formulation for the maintenance treatment of chronic obstructive pulmonary disease [3] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.05 million shares at a cost of about HK$105 million, with buyback prices ranging from HK$95.35 to HK$96.3 [3] - Hang Seng Bank (00011.HK) repurchased 200,000 shares at a cost of approximately HK$22.717 million, with buyback prices between HK$113.1 and HK$114.2 [4]
上美股份发盈喜 预计中期利润增加约30.9%至35.8%
Zhi Tong Cai Jing· 2025-08-05 11:37
Core Viewpoint - The company expects significant revenue and profit growth for the six months ending June 30, 2025, driven by its skincare brands and product diversification [1] Revenue Summary - The projected revenue for the six months ending June 30, 2025, is estimated to be between approximately RMB 40.90 billion and RMB 41.10 billion, representing an increase of about 16.8% to 17.3% compared to the revenue of approximately RMB 35.024 billion for the six months ending June 30, 2024 [1] Profit Summary - The anticipated profit for the same period is expected to be between approximately RMB 5.40 billion and RMB 5.60 billion, which indicates an increase of about 30.9% to 35.8% compared to the profit of approximately RMB 4.124 billion for the six months ending June 30, 2024 [1] Growth Drivers - The revenue and profit increase is primarily attributed to the continuous growth from the scientific anti-aging skincare brand Han Shu and the significant year-on-year revenue increase from the Chinese infant skincare brand Newpage [1]
上美股份(02145.HK)盈喜:预期中期利润同比增加约30.9%至35.8%
Ge Long Hui· 2025-08-05 11:35
根据目前可得资料,收入及利润增加主要由于集团科学抗衰护肤品牌韩束全渠道多品类的布局带来的收 入持续增长及中国婴童功效护肤品牌newpage一页的收入同比大幅增长。 格隆汇8月5日丨上美股份(02145.HK)公告,集团截至2025年6月30日止6个月未经审核综合管理账目的初 步审阅及对董事会目前可获得资料的评估,集团预计(i)截至2025年6月30日止6个月的收入约人民币40.9 亿元至人民币41.1亿元,同比增加约16.8%至17.3%;及(ii)截至2025年6月30日止6个月的公司利润约人 民币5.4亿元至人民币5.6亿元,同比增加约30.9%至35.8%。 ...
上美股份(02145)发盈喜 预计中期利润增加约30.9%至35.8%
智通财经网· 2025-08-05 11:32
智通财经APP讯,上美股份(02145)发布公告,集团预计截至2025年6月30日止六个月的收入介于约人民 币40.90亿元至41.10亿元,较截至2024年6月30日止六个月的收入约人民币35.024亿元增加约16.8%至 17.3%;及截至2025年6月30日止六个月的公司利润介于约人民币5.40亿元至5.60亿元,较截至2024年6月 30日止六个月的公司利润约人民币4.124亿元增加约30.9%至35.8%。 收入及利润增加主要由于集团科学抗衰护肤品牌韩束全渠道多品类的布局带来的收入持续增长及中国婴 童功效护肤品牌newpage一页的收入同比大幅增长。 ...
上美股份(02145) - 正面盈利预告
2025-08-05 11:23
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 Shanghai Chicmax Cosmetic Co., Ltd. 上海上美化妝品股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:2145) 正面盈利預告 本公告乃由上海上美化妝品股份有限公司(「本公司」,連同其附屬公司統稱「本集 團」)根據香港聯合交易所有限公司證券上市規則(「上市規則」)第13.09(2)(a)條及 證券及期貨條例(香港法例第571章)第XIVA部項下的內幕消息條文(定義見上市 規則)作出。 本公司董事會(「董事會」)謹此知會本公司股東(「股東」)及有意投資者,基於對 本集團截至2025年6月30日止六個月未經審核綜合管理賬目的初步審閱及對董事 會目前可獲得資料的評估,本集團預計(i)截至2025年6月30日止六個月的收入介 乎約人民幣4,090.0百萬元至人民幣4,110.0百萬元,較截至2024年6月30日止六 個月的收入約人民幣3,502.4百萬元增加約 ...
上美股份20250730
2025-08-05 03:20
Summary of Shangmei Co., Ltd. Conference Call Company Overview - Shangmei Co., Ltd. reported a revenue of 6.7 billion RMB in 2024, representing a year-on-year growth of 62.1%, with net profit increasing by 74% [2][3] - The company was founded in 2002 and focuses on skincare, hair care, and maternal and infant products, with brands including Han Shu, New Page, Yi Ye Zi, Red Elephant, and Anminyou [3] Core Strategies and Insights - **Brand Premiumization Strategy**: Shangmei adopts a dual-track strategy for brand premiumization, enhancing product efficacy through self-developed core ingredients (e.g., Anminyou's artemisinin oil) and IP collaborations (e.g., with the "Anpanman" brand for maternal and infant care) [2][4] - **Channel Strategy Adjustment**: The company is shifting from a heavy focus on Douyin to a multi-channel approach, with Douyin's channel share slightly decreasing to 75% in Q1 2025, while Tmall and JD.com are gaining share [2][6] - **"2+2+2" Brand Strategy**: This strategy targets mass, mid-to-high-end, and high-end markets across skincare, maternal and infant care, and hair care categories [2][7] Product Performance - **Han Shu Brand**: Han Shu's red waist series 2.0 version has sold over 14 million sets, and new high-margin products like Chatai Super Frequency Cream are expected to enhance profitability [2][8] - **Growth Projections**: The Han Shu brand is expected to achieve approximately 20% growth in 2025, driven by anti-aging, men's skincare, and color cosmetics segments [2][9] Future Growth Drivers - **Emerging Brands**: New Page is rapidly growing in the maternal and infant care market, with plans to expand into teenage care and color cosmetics [2][9] - **New Product Launches**: The upcoming brands, such as Nambeauty and the Anpanman collaboration, are projected to achieve over 100 million RMB in sales in their first year [2][9] Profitability Enhancement Measures - **High-Margin Product Focus**: Increasing the proportion of high-margin new products, such as Han Shu's new offerings, is expected to boost overall gross and net profit margins [2][10] - **Channel Optimization**: A strategic reduction in the proportion of live streaming sales and an increase in self-broadcasting and high-margin channels like Tmall and JD.com will enhance profitability [2][10] - **Sales Expense Reduction**: The company anticipates a gradual decrease in sales expense ratio, projected to drop by about 1 percentage point annually from 2025 to 2027 [2][10] Financial Outlook - Shangmei is expected to achieve revenue growth rates of 24.1%, 20.8%, and 20.7% from 2025 to 2027, with adjusted net profits growing by 33.8%, 21.4%, and 18.8% respectively [2][10]